Completed NA INTERVENTIONAL 1-arm NCT01975584

Neuroendocrine and Immune Response to Stress in Schizophrenia (TSST)

Sponsor: University of Maryland, Baltimore

Conditions Schizoaffective Disorder Schizophrenia

Updated 9 times since 2017 Last updated: Sep 25, 2019 Started: Sep 30, 2013 Primary completion: Jun 30, 2018 Completion: Jun 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Schizoaffective Disorder and Schizophrenia and is currently completed. University of Maryland, Baltimore leads this study, which shows 9 recorded versions since 2013 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Oct 2019 — Jan 2021 [monthly]

Completed NA
Sep 2019 — Oct 2019 [monthly]

Completed NA

▶ Show 4 earlier versions

Aug 2018 — Sep 2019 [monthly]

Completed NA

Status: Recruiting → Completed
Jun 2018 — Aug 2018 [monthly]

Recruiting NA
Aug 2017 — Jun 2018 [monthly]

Recruiting NA
Jan 2017 — Aug 2017 [monthly]

Recruiting NA

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Maryland, Baltimore

Data source: University of Maryland, Baltimore

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Catonsville, United States